Enzene Biosciences
India - PuneBiotechnology
Focus: Enzene Biosciences is an India-based biotechnology company specializing in biosimilars and peptide therapeutics across ophthalmology, neurology, and gastroenterology indications. The company is in early-to-mid stage development with a focused pipeline.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Enzene Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Enzene Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ENZ215
Healthy Male SubjectsClinical Trials (1)
NCT05245669Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Phase 1Help build intelligence for Enzene Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.